Novel androgen receptor co-regulator GRHL2 exerts both oncogenic and anti-metastatic functions in prostate cancer

Alterations to the expression and activity of androgen receptor (AR) co-regulators in prostate cancer is an important mechanism driving disease progression and therapy resistance. Using a novel proteomic technique, we identified a new AR co-regulator, the transcription factor Grainyhead-like 2 (GRHL...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res
Main Authors: Paltoglou, Steve, Das, Rajdeep, Townley, Scott L., Hickey, Theresa E., Tarulli, Gerard A., Coutinho, Isabel, Fernandes, Rayzel, Hanson, Adrienne R., Denis, Iza, Carroll, Jason S., Dehm, Scott M., Raj, Ganesh V., Plymate, Stephen R., Tilley, Wayne D., Selth, Luke A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5497757/
https://ncbi.nlm.nih.gov/pubmed/28473532
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-16-1616
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados